Alibaba doubles down on healthcare AI with new tool for early colorectal cancer detection
SCMP Tech / 4/28/2026
📰 NewsSignals & Early TrendsTools & Practical UsageIndustry & Market Moves
Key Points
- AlibabaのDAmo Academyが、早期の大腸がん検出を目的とした医療AIツール「Coca AI」を発表し、医用画像スクリーニングの精度向上を狙っている。
- 同社は、27,000人超のCTスキャン（画像）データを用いた検証で、これまで見逃されていた5件の症例をCoca AIが新たに正確に特定できたとしている。
- この取り組みは、医療現場での早期発見・見逃し低減にAIを適用する動きの強化として位置づけられる。
- ツールの実用化に向けては、臨床データでの再現性や運用面（ワークフロー統合、精度保証、バイアス管理等）が今後の焦点になる。
Alibaba Group Holding has released an artificial intelligence model that it claims is more sensitive than radiologists in spotting early stage colorectal cancer from computed tomography (CT) scans, as the Chinese tech giant doubles down on its efforts to develop AI tools for cancer detection.
Alibaba’s research arm Damo Academy said on Tuesday that its new Coca AI model accurately identified five previously missed cases of colorectal cancer from the non-contrast CT scans of more than 27,000...
Continue reading this article on the original site.
Read original →Related Articles
Black Hat USA
AI Business
Vector DB and ANN vs PHE conflict, is there a practical workaround? [D]
Reddit r/MachineLearning
Agent Amnesia and the Case of Henry Molaison
Dev.to
Azure Weekly: Microsoft and OpenAI Restructure Partnership as GPT-5.5 Lands in Foundry
Dev.to
Proven Patterns for OpenAI Codex in 2026: Prompts, Validation, and Gateway Governance
Dev.to
